Format

Send to

Choose Destination
Int J Mol Sci. 2017 Aug 11;18(8). pii: E1746. doi: 10.3390/ijms18081746.

Phellinus linteus Grown on Germinated Brown Rice Increases Cetuximab Sensitivity of KRAS-Mutated Colon Cancer.

Author information

1
Department of Food Biotechnology, Gachon University, Kyungji-Do 13120, Korea. nimpi79@hanmail.net.
2
Department of Food Biotechnology, Division of Bioindustry, Silla University, Busan 46958, Korea. parkjb928@daum.net.
3
Department of Food Biotechnology, Division of Bioindustry, Silla University, Busan 46958, Korea. sans76@silla.ac.kr.
4
The Research Center for Extremophiles & Marine Microbiology, Silla University, Busan 46958, Korea. sans76@silla.ac.kr.
5
Department of Food Biotechnology, Division of Bioindustry, Silla University, Busan 46958, Korea. songmj@silla.ac.kr.

Abstract

Colon cancer is one of the most common types of cancer, and it has recently become a leading cause of death worldwide. Among colon cancers, the v-ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutated form is notorious for its non-druggable features. Cetuximab, a monoclonal antibody that binds to the epidermal growth factor receptor, has been introduced as an antitumor therapy; however, secondary resistance and side effects significantly limit its effective use in these cancers. In this study, we prepared Phellinuslinteus on germinated brown rice (PBR) extracts to increase the sensitivity of KRAS-mutated colon cancers to cetuximab. The combined treatment of PBR extract and cetuximab suppressed SW480 cell viability/proliferation, with the cells exhibiting altered cellular morphology and clonogenic potential. AnnexinV-fluorescein isothiocyanate/propidium iodide-stained flow cytometry and Western blotting were performed, and PBR extract combined with cetuximab treatment increased apoptosis of the SW480 cells and suppressed their KRAS protein expression. The potential of PBR as a synergistic anticancer agent was further investigated in a tumor-xenografted mouse model. Tumor growth was significantly suppressed with PBR extract and cetuximab co-treatment. In conclusion, PBR increased the sensitivity of KRAS-mutated colon cancer cells to cetuximab, which indicates the potential use of PBR as a medical food against colon cancer.

KEYWORDS:

Kirsten rat sarcoma viral oncogene homolog; Phellinuslinteus; cetuximab; colorectal cancer; drug sensitivity; β-glucan

PMID:
28800074
PMCID:
PMC5578136
DOI:
10.3390/ijms18081746
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center